Vaccine will generate 73% more than forecast based on contracts signed until mid-April
Photograph: Frederic J Brown/AFP/Getty ImagesPhotograph: Frederic J Brown/AFP/Getty Imagesexpects to make $26bn in revenues from sales of its Covid-19 vaccine this year, with its soaraway product accounting for more than a third of the company’s annual income.
Belgique Dernières Nouvelles, Belgique Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
COVID-19: Pfizer says demand for vaccine could be long-lasting like flu jabUS drugs giant Pfizer has said demand for its COVID-19 vaccine could become 'durable' like flu jabs as it reported revenues of $3.5bn for the drug in the first quarter
Lire la suite »
COVID-19: US regulators authorise use of Pfizer vaccine for ages 12 to 15The move offers protection for young people in the US before they head back to school in the autumn.
Lire la suite »
Pfizer asks UK regulator to approve Covid vaccine for children aged 12 to 15PFIZER has asked the UK regulator to approve its Covid vaccine for children aged 12 to 15, it’s reported. The pharma giant has applied to the Medicines and Healthcare products Regulatory Agen…
Lire la suite »
Pfizer expects Covid vaccine demand for yearsThe US drugs giant says demand for the vaccine is likely to be 'durable' in a similar way to flu jabs.
Lire la suite »
COVID-19: First nationwide data from Israel shows 95% protection from infection after two doses of Pfizer jabThe study uses data from between 24 January and 3 April, when the UK variant was responsible for most of Israel's infections.
Lire la suite »